Patents by Inventor Aaron Dulgar-Tulloch

Aaron Dulgar-Tulloch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11748683
    Abstract: A method for monitoring and recording a process in a clean space and a system for implementing same are provided. The method involves providing an electronic process record to a user using at least one processor; monitoring, using at least one sensor, for an event associated with the electronic process record; detecting, using the at least one sensor, the event associated with the electronic process record; recording in at least one data storage, using the at least one processor, information associated with the detected event, the recorded information being associated with a record of the electronic process record in the at least one data storage; verifying, using the at least one processor in communication with the at least one data storage, the recorded information; and storing in the at least one data storage, using the at least one processor, an indication that the recorded information has been verified.
    Type: Grant
    Filed: February 14, 2022
    Date of Patent: September 5, 2023
    Assignee: CENTRE FOR COMMERCIALIZATION OF REGENERATIVE MEDICINE
    Inventors: Spencer W. Hoover, Aaron Dulgar-Tulloch, Scott Genin, Nicholas Timmins, Steven Keizer, Aron Sankar, Howard Kim
  • Publication number: 20220237535
    Abstract: A method for monitoring and recording a process in a clean space and a system for implementing same are provided. The method involves providing an electronic process record to a user using at least one processor; monitoring, using at least one sensor, for an event associated with the electronic process record; detecting, using the at least one sensor, the event associated with the electronic process record; recording in at least one data storage, using the at least one processor, information associated with the detected event, the recorded information being associated with a record of the electronic process record in the at least one data storage; verifying, using the at least one processor in communication with the at least one data storage, the recorded information; and storing in the at least one data storage, using the at least one processor, an indication that the recorded information has been verified.
    Type: Application
    Filed: February 14, 2022
    Publication date: July 28, 2022
    Inventors: Spencer W. Hoover, Aaron Dulgar-Tulloch, Scott Genin, Nicholas Timmins, Steven Keizer, Aron Sankar, Howard Kim
  • Patent number: 11282015
    Abstract: A method for monitoring and recording a process in a clean space and a system for implementing same are provided. The method involves providing an electronic process record to a user using at least one processor; monitoring, using at least one sensor, for an event associated with the electronic process record; detecting, using the at least one sensor, the event associated with the electronic process record; recording in at least one data storage, using the at least one processor, information associated with the detected event, the recorded information being associated with a record of the electronic process record in the at least one data storage; verifying, using the at least one processor in communication with the at least one data storage, the recorded information; and storing in the at least one data storage, using the at least one processor, an indication that the recorded information has been verified.
    Type: Grant
    Filed: February 21, 2018
    Date of Patent: March 22, 2022
    Assignee: CENTRE FOR COMMERCIALIZATION OF REGENERATIVE MEDICINE
    Inventors: Spencer W. Hoover, Aaron Dulgar-Tulloch, Scott Genin, Nicholas Timmins, Steven Keizer, Aron Sankar, Howard Kim
  • Patent number: 11254903
    Abstract: The present invention relates to cell culture in bioreactors, such as flexible cellbag bioreactors. More closely the invention relates to a method and system for determining the cell density in a bioreactor culture and for controlling the perfusion rate of a suspension culture of cells in a bioreactor, comprising measuring the oxygen uptake of primary mononuclear cells in a non-static bioreactor.
    Type: Grant
    Filed: July 9, 2015
    Date of Patent: February 22, 2022
    Assignee: CYTIVA SWEDEN AB
    Inventors: Michelle Louise Janas, Aaron Dulgar Tulloch, Clive Glover
  • Publication number: 20210142235
    Abstract: A method for monitoring and recording a process in a clean space and a system for implementing same are provided. The method involves providing an electronic process record to a user using at least one processor; monitoring, using at least one sensor, for an event associated with the electronic process record; detecting, using the at least one sensor, the event associated with the electronic process record; recording in at least one data storage, using the at least one processor, information associated with the detected event, the recorded information being associated with a record of the electronic process record in the at least one data storage; verifying, using the at least one processor in communication with the at least one data storage, the recorded information; and storing in the at least one data storage, using the at least one processor, an indication that the recorded information has been verified.
    Type: Application
    Filed: February 21, 2018
    Publication date: May 13, 2021
    Inventors: Spencer W. Hoover, Aaron Dulgar-Tulloch, Scott Genin, Nicholas Timmins, Steven Keizer, Aron Sankar, Howard Kim
  • Publication number: 20170211027
    Abstract: The present invention relates to cell culture in bioreactors, such as flexible cellbag bioreactors.
    Type: Application
    Filed: July 9, 2015
    Publication date: July 27, 2017
    Inventors: Michelle Louise JANAS, Aaron DULGAR TULLOCH, Clive GLOVER
  • Patent number: 8647829
    Abstract: Methods and kits for binding and releasing biological targets, comprising, a binder comprising an environmentally reactive molecular switch that can switch between a high affinity state, to bind the target, to a low affinity state, to release the target.
    Type: Grant
    Filed: July 7, 2009
    Date of Patent: February 11, 2014
    Assignee: General Electric Company
    Inventors: Aaron Dulgar-Tulloch, Ernest William Kovacs, Evelina Roxana Loghin, Anup Sood
  • Patent number: 7790410
    Abstract: Provided herein are techniques for screening materials for hemocompatibility. Hemocompatible materials may be advantageous when incorporated into devices that may come into direct contact with blood or other bodily fluids. Such techniques take advantage of conformational changes in fibrinogen when adsorbed onto certain materials. As a result of conformational changes, the fibrinogen has altered responsiveness to cleavage by thrombin. Accordingly, the products of thrombin cleavage of fibrinogen may be assessed to determine the hemocompatibility of a material.
    Type: Grant
    Filed: April 25, 2008
    Date of Patent: September 7, 2010
    Assignee: General Electric Company
    Inventors: Liming Yu, Aaron Dulgar-Tulloch
  • Publication number: 20100216159
    Abstract: Methods and kits for binding and releasing biological targets, comprising, a binder comprising an environmentally reactive molecular switch that can switch between a high affinity state, to bind the target, to a low affinity state, to release the target.
    Type: Application
    Filed: July 7, 2009
    Publication date: August 26, 2010
    Applicant: GENERAL ELECTRIC COMPANY
    Inventors: Aaron Dulgar-Tulloch, Ernest William Kovacs, Evelina Roxana Loghin, Anup Sood
  • Publication number: 20090269790
    Abstract: Provided herein are techniques for screening materials for hemocompatibility. Hemocompatible materials may be advantageous when incorporated into devices that may come into direct contact with blood or other bodily fluids. Such techniques take advantage of conformational changes in fibrinogen when adsorbed onto certain materials. As a result of conformational changes, the fibrinogen has altered responsiveness to cleavage by thrombin. Accordingly, the products of thrombin cleavage of fibrinogen may be assessed to determine the hemocompatibility of a material.
    Type: Application
    Filed: April 25, 2008
    Publication date: October 29, 2009
    Applicant: General Electric Company
    Inventors: Liming Yu, Aaron Dulgar Tulloch